Targeting PD-1 + T cells with chimeric antigen receptors to reduce the HIV reservoir
Authors:
- Laura ErmellinoLELaura Ermellino
- Spiros GeorgakisSGSpiros Georgakis
- Nicole P. KadziochNKNicole P. Kadzioch
- Ana Alcaraz-SernaAAAna Alcaraz-Serna
- Oscar Alfageme-AbelloOAOscar Alfageme-Abello
- Raphaël PorretRPRaphaël Porret
- Rebecca CecchinRCRebecca Cecchin
- Michail OrfanakisMOMichail Orfanakis
- Rachel SchellingRSRachel Schelling
- Cloé BrennaCBCloé Brenna
Open Access
- 24 April 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (17) , eaeb7602
Abstract
The unique ability of chimeric antigen receptor (CAR) T cells to infiltrate tissues is revolutionizing our perspectives for tackling severe, refractory and otherwise untreatable diseases. In HIV, CAR-T cells have been designed to target viral biomarkers, with limited success so far. Here, we investigated the possibility of redirecting CAR-T cells against a cellular biomarker of the HIV reservoir, the programmed cell death protein 1 (PD-1). We designed two second-generation 4-1BB-CARs using the scFv of either a blocking (bPD1-CAR) or a nonblocking (nbPD1-CAR) anti–PD-1 monoclonal antibody. The CAR avidity modulated T cell sensitivity, trogocytosis, and effector functions, independently of the PD-1 signaling domain. Both anti–PD-1 CAR-T cells could persist for 70 days in HIV-infected humanized mice, correlating with viral protection and a disruption of the lymphoid architecture in the white pulp of the spleen. Together, our results open strategic avenues for reducing the HIV reservoir by demonstrating the feasibility of depleting specific T cell subpopulations.Keywords
All Related Versions
Funding Information
- Gabriella Giorgi-Cavaglieri Foundation
- Swiss Vaccine Institute
- Swiss Vaccine Institute
This publication has 68 references indexed in Scilit:
- Modelling HIV infection and therapies in humanised miceSwiss Medical Weekly, 2012
- A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cellsNature, 2010
- The HADDOCK web server for data-driven biomolecular dockingNature Protocols, 2010
- Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferationJournal of Experimental Medicine, 2007
- PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infectionJournal of Experimental Medicine, 2006
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionNature, 2006
- Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.2000
- Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cellsProceedings of the National Academy of Sciences, 1997
- Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells.1997
- Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors.1994